Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development, innovation and production have never stopped. Today, SIFI has evolved into an industrial group of companies, consolidating domestic leadership and expanding into international markets worldwide.
SIFI's mission is to improve people’s lives through meaningful innovation in eye care.
SIFI provides ophthalmologists and their patients with a wide range of therapeutic solutions, including innovative pharmaceuticals, medical devices and nutraceuticals.
SIFI concentrates its R&D and manufacturing in Italy and exports towards more than 20 countries with a direct presence in Italy, Spain, France, Romania, Mexico and Turkey.
Since June 2015, SIFI is backed by 21 Invest, a private equity firm founded by Alessandro Benetton, to support the company’s expansion strategy, which is based on establishing (or acquiring) direct commercial operations in major European markets and expanding its network of international distributors.
